<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>INDUSTRIAL PHARMACY-II</title>
    <link rel="stylesheet" href="1stsem.css">
</head>
<nav class="navbar">
    <div class="home"> <a href="index.html">Home</a></div>
    <div class="news"><a href="news.html">News</a></div>
    <div class="about"><a href="about.html">About</a></div>
    <div class="contact"><a href="contact.html">Contact</a></div>
 </nav>
<body>
    <header><H1><b><marquee>Pharma Tube</marquee></b></H1>
        <h3>Learn Well Earn Well</h3> </header>

        <main>
            <section>
                <p class="nameofsubject">INDUSTRIAL PHARMACY-II</p>
                <div class="hap">
                    <b><i><u> UNIT-1 </u></i></b>
                    <b>Pilot plant scale up techniques</b>
                    General considerations - including significance of 
                    personnel requirements, space requirements, raw materials, Pilot plant scale up 
                    considerations for solids, liquid orals, semi solids and relevant documentation, SUPAC 
                    guidelines, Introduction to platform technology
                     <a href="" download="I.P.-II unit-1" target="blank"  rel="norefferance"> UNIT-1 (Download) </a><div> <hr> </div>



                     <b><u><i> UNIT-2 </i></u></b>
                     <b>Technology development and transfer</b>
                     WHO guidelines for Technology Transfer(TT): 
                     Terminology, Technology transfer protocol, Quality risk management, Transfer from R 
                     & D to production (Process, packaging and cleaning), Granularity of TT Process (API, excipients, finished products, packaging materials) Documentation, Premises and 
                     equipments, qualification and validation, quality control, analytical method transfer, 
                     Approved regulatory bodies and agencies, Commercialization - practical aspects and 
                     problems (case studies), TT agencies in India - APCTD, NRDC, TIFAC, BCIL, TBSE / 
                     SIDBI; TT related documentation - confidentiality agreement, licensing, MoUs, 
                     legal issues.
                     <a href="" download="I.P.-II unit-2" target="blank"  rel="norefferance"> UNIT-2 (Download) </a><div> <hr> </div>




                     <b><u><i> UNIT-3 </i></u></b>
                     <b> Regulatory affairs: </b> Introduction, Historical overview of Regulatory Affairs, Regulatory
                     authorities, Role of Regulatory affairs department, Responsibility of Regulatory Affairs
                     Professionals.
                     <b> Regulatory requirements for drug approval:  </b>Drug Development Teams, Non-Clinical
                     Drug Development, Pharmacology, Drug Metabolism and Toxicology, General
                     considerations of Investigational New Drug (IND) Application, Investigator’s Brochure
                     (IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical Research
                     Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for
                     FDASubmissions, Management of Clinical Studies.
                    
                     <a href="" download="I.P.-II unit-3" target="blank"  rel="norefferance"> UNIT-3 (Download) </a><div> <hr> </div>





                     <b><u><i> UNIT-4 </i></u></b>
                     <b>  Quality management systems: </b>Quality management & Certifications: Concept of
                     Quality, Total Quality Management, Quality by Design (QbD), Six Sigma concept, Out
                     of Specifications (OOS), Change control, Introduction to ISO 9000 series of quality
                     systems standards, ISO 14000, NABL, GLP.
                     
                     <a href="" download="I.P.-II unit-4" target="blank"  rel="norefferance"> UNIT-4 (Download) </a><div> <hr> </div>



                     <b><u><i> UNIT-5 </i></u></b>
                     <b>  Indian Regulatory Requirements: </b> Central Drug Standard Control Organization
                     (CDSCO) and State Licensing Authority: Organization, Responsibilities, Certificate of
                     Pharmaceutical Product (COPP), Regulatory requirements and approval procedures for
                     New Drugs.
                     
                     <a href="" download="I.P.-II unit-5" target="blank"  rel="norefferance"> UNIT-5 (Download) </a>


                </div> 

            </section>
        </main>





        <footer><p class="foot"> © 2024 Pharma Tube. All rights reserved.</p></footer>

           
</body>
</html>